Azlin
Azlocillin Sodium
Sourced from the FDA Orange Book
Key dates
Key dates
Approval
FDA approval date of this drug product.
Sep 03, 1982
44 yr 6 mo ago
Today
Pharmaceutical detail
Pharmaceutical detail
Active ingredient
AZLOCILLIN SODIUM
Strength
EQ 2GM BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 050562
Product number
001
Marketing status
Discontinued
Reference listed drug (RLD)
No
Reference standard (RS)
No
Other strengths in NDA 050562
Active-ingredient family
This is a brand (NDA) product. Other products sharing this active ingredient are listed below.
View full Azlocillin Sodium familyListed patents
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Azlin — frequently asked questions
Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.
Built directly from the FDA Orange Book data file. This product page links back to the Azlocillin Sodium active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsThe list of FDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 & Inspection DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
